Flunitrazolam structure.png
Chemical and physical data
Molar mass337.307 g·mol−1
3D model (JSmol)

Flunitrazolam is a benzodiazepine derivative that has been sold online as a designer drug, and is a potent hypnotic and sedative drug similar to related compounds such as flunitrazepam, clonazolam and flubromazolam. It was first definitively identified and reported to the EMCDDA Early Warning System, by an analytical laboratory in Germany in October 2016,[1] and had not been described in the scientific or patent literature before this.[2][3]

See also[edit]


  1. ^ Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA
  2. ^ Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD. The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Test Anal. 2017;1–17. doi:10.1002/dta.2211
  3. ^ Cornett EM, et al. New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol. 2018 Jun;32(2):149-164. doi:10.1016/j.bpa.2018.06.007 PMID 30322456